We selected four loci that regulate B-cell specific function (SPIB (55), CD22 (56)) or are commonly mutated in DLBCL (BCL2L1 (57), NOL9 (58)) and for which DXM predicted an i-DMR in at least one but not all samples. Here, SPIB is linked to diffuse large B-cell lymphoma.